Actress Olivia Munn, honored as a 2026 Woman of the Year by Los Angeles Magazine, continues to sound the alarm on breast cancer early detection more than two years after her own shocking diagnosis of an aggressive form that presented with zero symptoms.

Munn, 45, revealed in a March 2024 Instagram post that she had been diagnosed with bilateral luminal B breast cancer in April 2023. Despite a recent normal mammogram and negative genetic testing for 90 cancer-related genes, including BRCA, her doctor’s decision to calculate her lifetime risk using the Tyrer-Cuzick Breast Cancer Risk Assessment Tool uncovered a 37.3% chance of developing the disease. That score prompted further imaging that detected fast-growing tumors in both breasts.

“There were no symptoms. No family history that raised red flags at the time. Just a simple risk assessment that changed everything,” Munn has repeatedly emphasized in interviews and public appearances. The tool, available free online, estimates a woman’s chance of developing breast cancer over her lifetime based on factors including age, reproductive history, breast density and family history.

Munn underwent a double mastectomy just 30 days after her biopsy confirmed stage 1 cancer present in multiple quadrants of both breasts. She has since had five surgeries, including a lymph node dissection, nipple-sparing procedures, a hysterectomy and removal of her ovaries and fallopian tubes to address hormone-driven risks and induce medical menopause. She also began a five-year course of hormone therapy.

In a recent appearance at the Los Angeles Magazine Women of Impact 2026 luncheon on March 13, Munn recounted her journey while accepting recognition for her advocacy. “I don’t look at cancer like, ‘I can’t believe I went through this, it’s really unfair.’ There’s no place in my mind and my energy to think about how things are unfair,” she said. “I just think thank God I’m one of the lucky ones.”

Her openness has had measurable impact. After her initial disclosure, visits to breast cancer risk assessment tools surged, with organizations like Susan G. Komen reporting significant increases. Munn’s story also inspired others directly: Inside Edition correspondent Alison Hall, who covered Munn’s diagnosis, took the same risk assessment, discovered elevated risk and was diagnosed with early-stage ductal carcinoma in situ.

In July 2025, Munn shared that her mother, Kim, also received a breast cancer diagnosis after Munn urged her and her sister to take the Tyrer-Cuzick test. Her mother was found to have stage 1 HER2-positive breast cancer, completed 12 rounds of chemotherapy and continues targeted treatments. “The same test that saved my life saved my mom’s life as well,” Munn wrote on social media.

Luminal B breast cancer, the subtype Munn faced, is known for being more aggressive and fast-growing than some other forms, often requiring prompt intervention. Experts note it can evade routine mammograms in denser breast tissue or when tumors are small, underscoring why risk assessment tools provide critical additional layers of information.

Munn has detailed the physical and emotional toll in candid interviews. She described the diagnosis as “terrifying,” especially as a new mother to son Malcolm, born in 2021 with partner comedian John Mulaney. “Having a little baby at home made everything much more terrifying,” she told People magazine. Treatments led to surgical menopause, bringing symptoms like hot flashes, joint pain, fatigue, hair thinning and brain fog.

Yet she has embraced a philosophy of resilience. At the 2025 TIME Women of the Year gala, Munn spoke of hitting “a good stride” despite ongoing medication adjustments and the reality of years of treatment ahead. She told outlets she is learning to go easier on herself and appreciates life more deeply. “I have years to go in my cancer treatment,” she acknowledged, while celebrating good days when symptoms ease.

Munn’s advocacy focuses heavily on empowering women to advocate for themselves in medical settings. She stresses that standard mammograms and even genetic tests like BRCA screening are not always enough, particularly for those with average or slightly elevated risk profiles. The Tyrer-Cuzick model, also known as the IBIS tool, incorporates more variables and can flag women who might benefit from MRI or ultrasound follow-up.

Breast cancer remains the second most common cancer among women in the United States, with the American Cancer Society estimating about 310,000 new invasive cases in 2026. Early detection dramatically improves outcomes: when caught at localized stages, the five-year survival rate exceeds 99%. Munn’s case illustrates how even asymptomatic, early-stage disease can progress quickly if undetected.

Health organizations endorse risk assessment as a complement to regular screening. The American College of Radiology and others recommend women begin discussing individualized screening plans in their 20s or 30s, especially with any family history or dense breasts. Munn has shared links to the free online calculator in her social media bios and posts.

Beyond health advocacy, Munn has maintained a busy career. She stars in Apple TV+’s “Your Friends & Neighbors,” with season 2 premiering in early April 2026. She appeared at press events in late March 2026, looking healthy and focused on the project while continuing to weave in messages about breast health.

In October 2025, she received the Excellence in Cancer Awareness Award from the Prevent Cancer Foundation, where she reiterated her message: “Olivia Munn was diagnosed with breast cancer with no symptoms, no family history and no warning signs — just one test that changed everything.”

Munn has also opened up about fertility considerations. Before her hysterectomy, she explored egg retrieval options, mindful of the impact on future family plans. She has expressed hope that sharing these intimate details helps normalize conversations around cancer treatment’s broader effects on women’s lives.

Her journey has resonated across Hollywood and beyond. At the 2025 TIME Women of the Year event and other honors, Munn highlighted gratitude for her medical team and support system, including Mulaney, who helped break the news to family members when emotions overwhelmed her.

Medical experts caution that while Munn’s experience highlights the value of risk tools, decisions about additional screening should involve consultation with physicians. Not every high-risk score leads to cancer, and over-testing carries its own considerations.

Munn continues hormone therapy and regular monitoring. In February 2026 interviews, she provided updates on her mother’s ongoing battle, expressing pride in her family’s proactive steps.

As she balances motherhood, acting and advocacy, Munn’s core message remains consistent: know your risk, ask questions and don’t hesitate to push for more thorough evaluation if something feels off — even with clean routine tests.

“I hope by sharing this it will help others find comfort, inspiration and support on their own journey,” she wrote in her original 2024 post. That sentiment has guided her public platform ever since, turning a private health crisis into a widespread call for vigilance.

With breast cancer awareness efforts ongoing year-round, Munn’s story serves as a powerful reminder that early detection tools and personal advocacy can be lifesaving — sometimes before any symptoms appear.